麦肯锡给医药行业的报告.pptxVIP

McKinsey was commissioned in Q1, 2003 to: provide dedicated effort in conducting in-depth market survey and collect detailed information from 4 cities within 2 provinces to identify the key growth drivers in China’s broad market; 4 product categories were included: G.I. (Motilium), OBGY (Gyno.), Nail Infection (Sporanox) Vertigo (Sibelium) provide objective assessment about the broad market opportunity (not including any urban centres); provide business model / proposal for XJP to capture the broad market;McKinsey Broad Market Study Process;;BROAD MARKET DRUGS INCLUDE OTC AND “OUT PATIENT” Rx